Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q1 2023 Results - Earnings Call Transcript
Medicenna Therapeutics Corp. (NASDAQ:NASDAQ:MDNA) Q1 2023 Earnings Conference Call August 15, 2022, 08:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant -...
Source: seekingalpha.com